Peroxisome proliferators (PPs) are chemicals of industrial and pharmaceutical importance that elicit liver carcinogenesis by a non-genotoxic mechanism. One of the intriguing properties of PPs is that the pleiotropic effects of these compounds (including increased DNA synthesis and peroxisome proliferation) are seen in rats and mice only, but not humans. It is important to determine the risks to humans of environmental and therapeutic exposure to these compounds by understanding the mechanisms of non-genotoxic hepatocarcinogenesis in rodents. To understand this apparent lack of human susceptibility, attention has focused on the peroxisome proliferator-activated receptor alpha (PPARalpha), which appears to mediate the effects of PPs in rodents. It is also known to mediate the hypolipidaemic effects that fibrate drugs exert on humans with elevated plasma cholesterol and triglyceride levels. Human PPARalphas share many functional characteristics with the rodent receptors, in that they can be transcriptionally activated by PPs and regulate specific gene expression. However, one key difference is that PPARalpha is less abundant in human than in rodent liver, which has led to the suggestion that species differences result from quantitative differences in gene expression. In this review we describe the effects of PPs and what is known of the molecular mechanisms of action and species differences with respect to rodents and man. Attention will be given to differences in the amounts of PPARalpha between species as well as the 'qualitative' aspects of PPARalpha-mediated gene regulation which might also explain the activation of some genes and not of others in human liver by PPs.

This article has been cited by other articles:

				A. J. Nilsen, M. A. Landin, K. H. Haug, F. Fonnum, U. Berger, and H. Osmundsen Comparative hepatic gene expression profiling of rats treated with 1H,1H,2H,2H-heptadecafluorodecan-1-ol or with pentadecafluorooctanoic acid Physiol Genomics, August 14, 2008; 34(3): 285 - 303. [Abstract] [Full Text] [PDF]

				A. Koch, B. Konig, J. Spielmann, A. Leitner, G. I. Stangl, and K. Eder Thermally Oxidized Oil Increases the Expression of Insulin-Induced Genes and Inhibits Activation of Sterol Regulatory Element-Binding Protein-2 in Rat Liver J. Nutr., September 1, 2007; 137(9): 2018 - 2023. [Abstract] [Full Text] [PDF]

				S. Luci, B. Giemsa, H. Kluge, and K. Eder Clofibrate causes an upregulation of PPAR-{alpha} target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R70 - R77. [Abstract] [Full Text] [PDF]

				R. Ringseis, A. Muschick, and K. Eder Dietary Oxidized Fat Prevents Ethanol-Induced Triacylglycerol Accumulation and Increases Expression of PPAR{alpha} Target Genes in Rat Liver J. Nutr., January 1, 2007; 137(1): 77 - 83. [Abstract] [Full Text] [PDF]

				M. H. Vickers, P. L. Hofman, P. D. Gluckman, P. E. Lobie, and W. S. Cutfield Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1212 - E1219. [Abstract] [Full Text] [PDF]

				S. Luci, H. Kluge, F. Hirche, and K. Eder Clofibrate Increases Hepatic Triiodothyronine (T3)- and Thyroxine (T4)-Glucuronosyltransferase Activities and Lowers Plasma T3 and T4 Concentrations in Pigs Drug Metab. Dispos., November 1, 2006; 34(11): 1887 - 1892. [Abstract] [Full Text] [PDF]

				Y. Cheon, T. Y. Nara, M. R. Band, J. E. Beever, M. A. Wallig, and M. T. Nakamura Induction of overlapping genes by fasting and a peroxisome proliferator in pigs: evidence of functional PPAR{alpha} in nonproliferating species Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1525 - R1535. [Abstract] [Full Text] [PDF]

				J. R. Foster Spontaneous and Drug-Induced Hepatic Pathology of the Laboratory Beagle Dog, the Cynomolgus Macaque and the Marmoset Toxicol Pathol, January 1, 2005; 33(1): 63 - 74. [Abstract] [Full Text] [PDF]

				T. Kino and G. P. Chrousos Combating Atherosclerosis With LXR{alpha} And PPAR{alpha} Agonists: Is Rational Multitargeted Polypharmacy the Future of Therapeutics in Complex Diseases? Mol. Interv., October 1, 2004; 4(5): 254 - 257. [Abstract] [Full Text] [PDF]

				K. Kuwabara, K. Murakami, M. Todo, T. Aoki, T. Asaki, M. Murai, and J. Yano A Novel Selective Peroxisome Proliferator-Activated Receptor {alpha} Agonist, 2-Methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), Potently Decreases Plasma Triglyceride and Glucose Levels and Modifies Lipoprotein Profiles in KK-Ay Mice J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 970 - 977. [Abstract] [Full Text] [PDF]

				F. Yadetie, A. Laegreid, I. Bakke, W. Kusnierczyk, J. Komorowski, H. L. Waldum, and A. K. Sandvik Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-{alpha} agonist ciprofibrate Physiol Genomics, September 29, 2003; 15(1): 9 - 19. [Abstract] [Full Text] [PDF]

				J.-M. Ye, M. A. Iglesias, D. G. Watson, B. Ellis, L. Wood, P. B. Jensen, R. V. Sorensen, P. J. Larsen, G. J. Cooney, K. Wassermann, et al. PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E531 - E540. [Abstract] [Full Text] [PDF]

				A. Soria, C. Bocos, and E. Herrera Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats J. Lipid Res., January 1, 2002; 43(1): 74 - 81. [Abstract] [Full Text] [PDF]

				P.-M. Chao, C.-Y. Chao, F.-J. Lin, and C.-j. Huang Oxidized Frying Oil Up-Regulates Hepatic Acyl-CoA Oxidase and Cytochrome P450 4 A1 Genes in Rats and Activates PPAR{alpha} J. Nutr., December 1, 2001; 131(12): 3166 - 3174. [Abstract] [Full Text] [PDF]

				X. X. Yu, J. Odle, and J. K. Drackley Differential induction of peroxisomal beta -oxidation enzymes by clofibric acid and aspirin in piglet tissues Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1553 - R1561. [Abstract] [Full Text] [PDF]

				R. Ge, W. Wang, P. M. Kramer, S. Yang, L. Tao, and M. A. Pereira Wy-14,643-Induced Hypomethylation of the c-myc Gene in Mouse Liver Toxicol. Sci., July 1, 2001; 62(1): 28 - 35. [Abstract] [Full Text] [PDF]

				J.-M. Ye, P. J. Doyle, M. A. Iglesias, D. G. Watson, G. J. Cooney, and E. W. Kraegen Peroxisome Proliferator--Activated Receptor (PPAR)-{alpha} Activation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat--Fed Rats: Comparison With PPAR-{gamma} Activation Diabetes, February 1, 2001; 50(2): 411 - 417. [Abstract] [Full Text]

				K. Yoshinari, T. Sueyoshi, R. Moore, and M. Negishi Nuclear Receptor CAR as a Regulatory Factor for the Sexually Dimorphic Induction of CYP2B1 Gene by Phenobarbital in Rat Livers Mol. Pharmacol., February 1, 2001; 59(2): 278 - 284. [Abstract] [Full Text]

				A. Minnich, N. Tian, L. Byan, and G. Bilder A potent PPAR{alpha} agonist stimulates mitochondrial fatty acid {beta}-oxidation in liver and skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E270 - E279. [Abstract] [Full Text] [PDF]

				C. Chen, G. E. Hennig, H. E. Whiteley, J. C. Corton, and J. E. Manautou Peroxisome Proliferator-Activated Receptor Alpha-Null Mice Lack Resistance to Acetaminophen Hepatotoxicity following Clofibrate Exposure Toxicol. Sci., October 1, 2000; 57(2): 338 - 344. [Abstract] [Full Text] [PDF]

				M.-C. Vohl, P. Lepage, D. Gaudet, C. G. Brewer, C. Bétard, P. Perron, G. Houde, C. Cellier, J. M. Faith, J.-P. Després, et al. Molecular scanning of the human PPARa gene: association of the L162V mutation with hyperapobetalipoproteinemia J. Lipid Res., June 1, 2000; 41(6): 945 - 952. [Abstract] [Full Text]

				J. W. Lawrence, Y. Li, S. Chen, J. G. DeLuca, J. P. Berger, D. R. Umbenhauer, D. E. Moller, and G. Zhou Differential Gene Regulation in Human Versus Rodent Hepatocytes by Peroxisome Proliferator-activated Receptor (PPAR) alpha . PPARalpha FAILS TO INDUCE PEROXISOME PROLIFERATION-ASSOCIATED GENES IN HUMAN CELLS INDEPENDENTLY OF THE LEVEL OF RECEPTOR EXPRESSION J. Biol. Chem., August 17, 2001; 276(34): 31521 - 31527. [Abstract] [Full Text] [PDF]